Moderna waiting for approval in Europe and America
Kathmandu. The American biopharmaceutical company, Moderna, is currently asking for approval in the countries of America and Europe.
Last week, Moderna announced that the final results on its mRNA-1273 Coronavirus vaccine has confirmed it to be 94 percent effective. Out of 185 covid-19 patients shot with Moderna’s vaccine, only 11 cases were found to be severe.
Earlier last month, Moderna had claimed its vaccine as 94.5 percent effective after the preliminary data on its three-phased experimental study. Similarly, another company, Pfizer had claimed its vaccine with 90 percent efficacy.
Earlier in September, The company had enrolled 30,000 volunteers who were given two shots of the vaccine. The authorities were waiting for the patients to get ill so that they could collect data from them. At least 53 research participants needed to become ill with COVID-19 in order for the vaccine to be considered for authorization by the US Food and Drug Administration (FDA).
Moderna had released a 135-page blueprint document that revealed that the mRNA-1273 vaccine is the first of its kind which “instead of preventing infection, teaches the body to better fight the virus”, and hopefully will reduce its severity to that of a common cold.
Facebook Comment
Related News
latest Video
Trending News
- This Week
- This Month
